Clinical Pain

Korean Association of Pain Medicine (대한임상통증학회)
권호 표지
DOI QR코드

DOI QR Code

Radiation Recall Myositis during Gemcitabine Chemotherapy

젬시타빈 항암치료 중 발생한 방사선 회상 근염

  • Park, Jin Ho (Department of Physical and Rehabilitation Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Yoon (Department of Rehabilitation Medicine, National Rehabilitation Center) ;
  • Yeo, Seung Mi (Department of Physical and Rehabilitation Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Hwang, Ji Hye (Department of Physical and Rehabilitation Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • 박진호 (성균관대학교 의과대학 삼성서울병원 재활의학교실) ;
  • 김윤 (국립재활원 재활의학과) ;
  • 여승미 (성균관대학교 의과대학 삼성서울병원 재활의학교실) ;
  • 황지혜 (성균관대학교 의과대학 삼성서울병원 재활의학교실)
  • Received : 2020.03.21
  • Accepted : 2020.06.10
  • Published : 2020.12.31
⟨ Previous Next ⟩

Abstract

Radiation recall is an uncommon phenomenon in which administration of a chemotherapy or another systemic agent induces an acute inflammatory reaction in previously irradiated tissues, often weeks to years after completion of radiotherapy. Gemcitabine can induce an inflammatory reaction within an area of prior radiation. Radiation recall is known to medical oncologists, however only few cases have been reported in Korean journals, therefore physiatrist who diagnose and treat the treatment-related physical impairments of cancer patients must know about it. We emphasize the importance of knowledge of this phenomenon when considering the differential diagnosis of painful limb edema in a patient who has received cancer treatment.

Keywords

References

  1. Burris HA, 3rd, Hurtig J. Radiation recall with anticancer agents. Oncologist 2010; 15: 1227-1237 https://doi.org/10.1634/theoncologist.2009-0090
  2. Eckardt MA, Bean A, Selch MT, Federman N. A child with gemcitabine-induced severe radiation recall myositis resulting in a compartment syndrome. J Pediatr Hematol Oncol 2013; 35: 156-161 https://doi.org/10.1097/MPH.0b013e31827e4c28
  3. Kim J, Yoo GS, Sinn DH, Park HC, Koh KC. Radiation-induced Myositis after Proton Beam Therapy to Huge Hepato-cellular Carcinoma. J Liver Cancer 2019; 19: 136-142 https://doi.org/10.17998/jlc.19.2.136
  4. Ryu YS, Jeon CH. A Case of Radiation Recall Myositis Induced by 5-FU and Cisplatin. J Rheum Dis 2012; 19: 59-62 https://doi.org/10.4078/jrd.2012.19.1.59
  5. Song SY, Noh YJ, Choi EK, Kim JH, Ahn SD, Lee S-w, et al. Gemcitabine-Related Radiation Recall in a Patient with Metastatic Non-small Cell Lung Cancer. J Lung Cancer 2008; 7: 98-100 https://doi.org/10.6058/jlc.2008.7.2.98
  6. Azria D, Magne N, Zouhair A, Castadot P, Culine S, Ychou M, et al. Radiation recall: a well recognized but neglected phenomenon. Cancer Treat Rev 2005; 31: 555-570 https://doi.org/10.1016/j.ctrv.2005.07.008
  7. Delavan JA, Chino JP, Vinson EN. Gemcitabine-induced radiation recall myositis. Skeletal Radiol 2015; 44: 451-455 https://doi.org/10.1007/s00256-014-1996-1
  8. Graf SW, Limaye VS, Cleland LG. Gemcitabine-induced radiation recall myositis in a patient with dermatomyositis. Int J Rheum Dis 2014; 17: 696-697 https://doi.org/10.1111/1756-185X.12233
  9. Camidge R, Price A. Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol 2001; 59: 237-245 https://doi.org/10.1016/S0167-8140(01)00328-0
  10. Ravishankar A, Park SS, Olivier KR, Corbin KS. Gemcitabine-Induced Radiation Recall Myositis: Case Report and Review of the Literature. Case Rep Oncol 2018; 11: 168-178 https://doi.org/10.1159/000487478